RHÖN-KLINIKUM Aktiengesellschaft
RKAGY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.09B
Close$
$5.39
33.9% downside
Current Fair Value
33.9% downsideOvervalued by 33.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.09 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.12 |
| Dividend yield | 1.39% |
| Earnings per Share | $0.25 |
| Beta | 0.08 |
| Outstanding Shares | 133,876,938 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 22.5 |
|---|---|
| PEG | 77.55 |
| Price to Sales | 0.68 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$445.74 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About RHÖN-KLINIKUM Aktiengesellschaft
19,120 employees
CEO: Tobias Kaltenbach
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectr...